UNH Unitedhealth (UNH) Insider Trading, Ownership & Congress Trades
Insurance · Hospital & medical service plans · CIK 0000731766
Congress · 5Form 144 · 2
Insider buyers, 180 days
0
Funds added, last quarter
1,837
13F, latest reported quarter
What the filings say about UNH
Insiders, 180 days
-$660.9K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
5 bought · 7 sold
Latest: sale, 2026-09-24
Planned sales (Form 144), 90 days
$660.9K
2 notices
Unitedhealth insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, UNITEDHEALTH GROUP INC insiders sold a net $660.9K of stock across 63 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 5, 2026.
- The trade is 7.6% of the 15,327 shares held after it.
- No other insider sold within 30 days.
- 1,837 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer, Optum Conway Patrick Hugh sold about $455.9K of UNH on Aug 21, 2026, the largest insider sale at the company since 2024; 1,837 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Apr 23, 2026.
- The trade is 3.0% of the 16,496 shares held after it.
- No other insider sold within 30 days.
- 1,837 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer, Optum Conway Patrick Hugh sold about $205.0K of UNH on Aug 5, 2026; 1,837 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Jun 10, 2025.
- The trade is 4.5% of the 17,804 shares held after it.
- No other insider sold within 30 days.
- 1,837 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer, Optum Conway Patrick Hugh sold about $284.0K of UNH on Apr 23, 2026, the largest insider sale at the company since 2024; 1,837 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- No other insider sold within 30 days.
- 1,837 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Baker Charles D. sold about $9.6K of UNH on Sep 11, 2025; 1,837 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 5.7% of the 10,398 shares held after it.
- No other insider sold within 30 days.
- 1,837 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer, Optum Conway Patrick Hugh sold about $179.6K of UNH on Jun 10, 2025; 1,837 funds added in the latest 13F quarter.63 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$660.9K over 180 days
-$660.9K over 90 days
more than 67% of Insurance
Congress
5 members bought in the last year
the highest in Insurance
Funds
1,837 funds bought in last quarter
more than 99% of Insurance
Revenue
+11.8% year over year
more than 58% of Insurance
Margin
2.7% net margin
below 77% of Insurance
Buybacks
$1.6B repurchased, FY to 2026-06-30
more than 92% of Insurance
Short interest
1.8% of the float short (float per yahoo 2026-10-26) · 3.3 days to cover · settled 2026-09-30
below 76% of Insurance
The situation: each line is one rule over one dataset
Federal contracts worth $7.1B were awarded in the last 180 days.
What changed in the last 30 days
Oct 13Rep. Kevin Hern sold $15K to $50K, disclosed 20 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Oct 7Rep. Maria Elvira Salazar sold $1.0K to $15K, disclosed 13 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Watch UNH
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+15.9%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns UNH: institutional holders (13F)
13F holdings, latest reported quarter
76,863,061 sh
$31.9B
59,311,525 sh
$24.7B
45,633,267 sh
$19.0B
29,887,932 sh
$12.4B
27,992,995 sh
$11.6B
Congress trades in UNH
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-09-24 · disclosed 13 days later
$1,001 - $15,000
Sold 2026-09-23 · disclosed 20 days later
$15,001 - $50,000
Sold 2026-09-10 · disclosed 15 days later
$15,001 - $50,000
Sold 2026-07-30 · disclosed 15 days later
$1,001 - $15,000
Sold 2026-07-10 · disclosed 7 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
UNH planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Conway Patrick Hugh
Filed 2026-08-21
$455.9K
Conway Patrick Hugh
Filed 2026-08-05
$205.0K
UNH mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Select Health Care Services Portfolio
$197.9M position · as of 2026-05-31
24.5%
iShares U.S. Healthcare Providers ETF
$258.1M position · as of 2026-06-30
21.9%
MARSHFIELD CONCENTRATED OPPORTUNITY FUND
$122.1M position · as of 2026-05-31
9.8%
Invesco Dow Jones Industrial Average Dividend ETF
$41.2M position · as of 2026-07-31
8.5%
Hennessy Total Return Fund
$3.9M position · as of 2026-07-31
7.7%
Putnam VT Global Health Care Fund
$10.7M position · as of 2026-06-30
7.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Government contracts
Award ceilings over the contract's life, subsidiaries included.
Not annual revenue (USASpending.gov).
Department Of Veterans Affairs
EXPRESS REPORT:R3 FY26 1ST QTR OCT · 2025-10-01
$1.1B
Department Of Veterans Affairs
EXPRESS REPORT: R3 FY26 4TH QTR JULY · 2026-07-01
$1.1B
Department Of Veterans Affairs
EXPRESS REPORT: 2ND QTR FY2026 MARCH · 2026-03-01
$988.2M
Department Of Veterans Affairs
R3 EXPRESS REPORT: 3RD QTR FY 2026 JUNE · 2026-06-01
$962.2M
Department Of Veterans Affairs
EXPRESS REPORT: 3RD QTR FY 2026 APRIL · 2026-04-01
$919.0M
Department Of Veterans Affairs
EXPRESS REPORT: 3RD QTR FY 2026 MAY · 2026-05-01
$918.5M
Federal awards ≥ $25M in the last 90 days, matched via the SAM.gov parent registry
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Unitedhealth Group Incorporated Pac (Unitedhealth Group Pac)
Cycle 2026 · $2,057K spent
$2.7M
Federal Election Commission, matched by the PAC's connected organisation
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $660.9K sold by insiders over 180 days, 1,837 funds added last quarter, 5 House member(s) bought in 12 months, disclosed weeks after the trade, $660.9K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
UNH financials
Revenue growth
+11.8%
XBRL, annual
Net margin
2.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$450.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM UNH
| FY Dec 2025 | $447.6B |
| FY Dec 2024 | $400.3B |
| FY Dec 2023 | $371.6B |
| FY Dec 2022 | $324.2B |
| FY Dec 2021 | $287.6B |
| Jun 2026 | $112.0B |
| Mar 2026 | $111.7B |
| Dec 2025 | $113.2B |
| Sep 2025 | $113.2B |
| Jun 2025 | $111.6B |
| Mar 2025 | $109.6B |
| Dec 2024 | $100.8B |
| Sep 2024 | $100.8B |
At each fiscal year end
Single quarter
Net margin, TTM
+3.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM UNH
| FY Dec 2025 | +2.7% |
| FY Dec 2024 | +3.6% |
| FY Dec 2023 | +6.0% |
| FY Dec 2022 | +6.2% |
| FY Dec 2021 | +6.0% |
| Jun 2026 | +4.9% |
| Mar 2026 | +5.6% |
| Dec 2025 | +0.0% |
| Sep 2025 | +2.1% |
| Jun 2025 | +3.1% |
| Mar 2025 | +5.7% |
| Dec 2024 | +5.5% |
| Sep 2024 | +6.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$23.6B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM UNH
| FY Dec 2025 | $16.1B |
| FY Dec 2024 | $20.7B |
| FY Dec 2023 | $25.7B |
| FY Dec 2022 | $23.4B |
| FY Dec 2021 | $19.9B |
| Jun 2026 | $10.3B |
| Mar 2026 | $8.1B |
| Dec 2025 | $160.0M |
| Sep 2025 | $5.1B |
| Jun 2025 | $6.3B |
| Mar 2025 | $4.6B |
| Dec 2024 | $1.5B |
| Sep 2024 | $13.0B |
At each fiscal year end
Single quarter
Debt to equity
0.70x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity UNH
| FY Dec 2025 | 0.78x |
| FY Dec 2024 | 0.78x |
| FY Dec 2023 | 0.66x |
| FY Dec 2022 | 0.71x |
| FY Dec 2021 | 0.61x |
| Jun 2026 | 0.70x |
| Mar 2026 | 0.75x |
| Dec 2025 | 0.78x |
| Sep 2025 | 0.79x |
| Jun 2025 | 0.79x |
| Mar 2025 | 0.81x |
| Dec 2024 | 0.78x |
| Sep 2024 | 0.78x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.37x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt UNH
| FY Dec 2025 | 0.25x |
| FY Dec 2024 | 0.31x |
| FY Dec 2023 | 0.46x |
| FY Dec 2022 | 0.45x |
| FY Dec 2021 | 0.49x |
| Jun 2026 | 0.37x |
| Mar 2026 | 0.30x |
| Dec 2025 | 0.25x |
| Sep 2025 | 0.26x |
| Jun 2025 | 0.37x |
| Mar 2025 | 0.35x |
| Dec 2024 | 0.31x |
| Sep 2024 | 0.21x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+13.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity UNH
| FY Dec 2025 | +12.2% |
| FY Dec 2024 | +15.0% |
| FY Dec 2023 | +25.5% |
| FY Dec 2022 | +25.7% |
| FY Dec 2021 | +24.1% |
| Jun 2026 | +13.8% |
| Mar 2026 | +11.8% |
| Dec 2025 | +12.2% |
| Sep 2025 | +17.5% |
| Jun 2025 | +21.8% |
| Mar 2025 | +22.9% |
| Dec 2024 | +15.0% |
| Sep 2024 | +15.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets UNH
| FY Dec 2025 | +4.0% |
| FY Dec 2024 | +5.0% |
| FY Dec 2023 | +8.6% |
| FY Dec 2022 | +8.8% |
| FY Dec 2021 | +8.4% |
| Jun 2026 | +4.6% |
| Mar 2026 | +3.9% |
| Dec 2025 | +4.0% |
| Sep 2025 | +5.7% |
| Jun 2025 | +7.2% |
| Mar 2025 | +7.4% |
| Dec 2024 | +5.0% |
| Sep 2024 | +4.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.6%
operating income after a 14.5% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital UNH
| FY Dec 2025 | +10.8% |
| FY Dec 2024 | +16.6% |
| FY Dec 2023 | +20.4% |
| FY Dec 2022 | +19.6% |
| FY Dec 2021 | +19.3% |
| Jun 2026 | +12.6% |
| Mar 2026 | +11.0% |
| Dec 2025 | +10.8% |
| Sep 2025 | +14.4% |
| Jun 2025 | +17.1% |
| Mar 2025 | +18.4% |
| Dec 2024 | +16.6% |
| Sep 2024 | +17.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+11.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed UNH
| FY Dec 2025 | +9.7% |
| FY Dec 2024 | +17.5% |
| FY Dec 2023 | +19.5% |
| FY Dec 2022 | +19.6% |
| FY Dec 2021 | +18.5% |
| Jun 2026 | +11.0% |
| Mar 2026 | +9.5% |
| Dec 2025 | +9.7% |
| Sep 2025 | +13.3% |
| Jun 2025 | +16.2% |
| Mar 2025 | +17.8% |
| Dec 2024 | +17.5% |
| Sep 2024 | +17.6% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.41x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing UNH
| FY Dec 2025 | 25.01x |
| FY Dec 2024 | 32.64x |
| FY Dec 2023 | 22.06x |
| FY Dec 2022 | 25.02x |
| FY Dec 2021 | 27.77x |
| Jun 2026 | 26.73x |
| Mar 2026 | 20.42x |
| Dec 2025 | 25.01x |
| Sep 2025 | 18.02x |
| Jun 2025 | 13.52x |
| Mar 2025 | 21.93x |
| Dec 2024 | 32.64x |
| Sep 2024 | 38.04x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$413.4B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value UNH
| FY Dec 2025 | $353.1B |
| FY Dec 2024 | $517.1B |
| FY Dec 2023 | $524.1B |
| FY Dec 2022 | $529.6B |
| FY Dec 2021 | $497.6B |
| Jun 2026 | $422.2B |
| Mar 2026 | $295.5B |
| Dec 2025 | $353.1B |
| Sep 2025 | $365.7B |
| Jun 2025 | $333.6B |
| Mar 2025 | $529.6B |
| Dec 2024 | $517.1B |
| Sep 2024 | $585.5B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield UNH
| FY Dec 2025 | +5.4% |
| FY Dec 2024 | +4.4% |
| FY Dec 2023 | +5.3% |
| FY Dec 2022 | +4.7% |
| FY Dec 2021 | +4.2% |
| Jun 2026 | +6.3% |
| Mar 2026 | +8.0% |
| Dec 2025 | +5.4% |
| Sep 2025 | +5.6% |
| Jun 2025 | +8.9% |
| Mar 2025 | +5.2% |
| Dec 2024 | +4.4% |
| Sep 2024 | +2.4% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -33%, PEG needs growth
PEG, trailing UNH
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 1.75x |
| FY Dec 2022 | 1.45x |
| FY Dec 2021 | 2.17x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 0.73x |
| Jun 2025 | 0.26x |
| Mar 2025 | 0.48x |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2025-12 | 2025-09 | 2025-06 | |
|---|---|---|---|---|
| Revenue | $447.6B | n/a | n/a | n/a |
| Operating income | $19.0B | n/a | n/a | n/a |
| Net income | $12.1B | n/a | n/a | n/a |
| EPS (diluted) | 13.23 | n/a | n/a | n/a |
| Operating cash flow | $19.7B | n/a | n/a | n/a |
| Cash | $24.4B | n/a | n/a | n/a |
| Long-term debt | $72.3B | n/a | n/a | n/a |
| Buybacks | $5.5B | n/a | n/a | n/a |
| Dividends paid | $7.9B | $2.0B | $2.0B | $2.0B |
SEC XBRL, fiscal years, as known on 2026-10-27
UNH Stock Sonar score 6/7 axes
Find similar shapesCompareUNH ranks highest on institutional and government (76th percentile) and risk and compliance (69th), and lowest on financial health (27th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
UNH filings, in plain words
Are Unitedhealth insiders buying or selling UNH?
In the 180 days to 2026-10-27, Unitedhealth insiders were net sellers, a net $660.9K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded UNH?
Yes. In the year to 2026-10-27, 5 House members disclosed buying UNH and 7 House members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24.
Are there planned insider sales of UNH?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $660.9K of stock; the latest, by Conway Patrick Hugh, was filed 2026-08-21.
Read the full summary
In the 180 days to 2026-10-27, Unitedhealth insiders were net sellers of UNH, a net $660.9K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-27, 5 members of Congress disclosed buying UNH and 7 members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $660.9K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
